Efficacy and Safety of Etrasimod (APD334) in Inflammatory Bowel Disease Patients With Active Skin Extra-intestinal Manifestations
Clinical trial NCT03139032 · TERMINATED
Trial details
- NCT number
- NCT03139032
- Sponsor
- Arena Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-17
- Primary completion
- 2017-12-06
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.